Drug Shortage Report for NAROPIN
| Report ID | 270404 |
| Drug Identification Number | 02229418 |
| Brand name | NAROPIN |
| Common or Proper name | ropivacaine HCl 10mg/mL 5x20mL SU Polyamp® Duofit® |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL |
| Packaging size | 5 PP Polyamp |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-07 |
| Estimated end date | 2025-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-18 |
| Company comments | VR89864CA1 NAROPIN 10MG/ML LIQ PP AMP 5X20ML CA ASP |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-11-18 | English | Compare |
| v2 | 2025-10-27 | French | Compare |
| v1 | 2025-10-27 | English | Compare |
Showing 1 to 3 of 3